<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04835415</url>
  </required_header>
  <id_info>
    <org_study_id>6777</org_study_id>
    <nct_id>NCT04835415</nct_id>
  </id_info>
  <brief_title>Ultrasound Guided Retrolaminar Block Versus Thoracic Epidural Analgesia Following Laparoscopic Cholecystectomy</brief_title>
  <official_title>Ultrasound Guided Retrolaminar Block Versus Thoracic Epidural Analgesia for Pain Control Following Laparoscopic Cholecystectomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Zagazig University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Zagazig University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to evaluate analgesic effect of ultrasound-guided retrolaminar block&#xD;
      vs ultrasound-guided thoracic epidural analgesia in pain control following laparoscopic&#xD;
      cholecystectomy.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      To study the difference between the effects of ultrasound-guided bilateral retrolaminar block&#xD;
      and ultrasound-guided thoracic epidural analgesia on pain control following laparoscopic&#xD;
      cholecystectomy. To relief pain and improve satisfaction in patients undergoing laparoscopic&#xD;
      cholecystectomy at Zagazig university hospitals.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 10, 2021</start_date>
  <completion_date type="Anticipated">July 30, 2021</completion_date>
  <primary_completion_date type="Anticipated">July 10, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Analgesia for postoperative pain after laparoscopic cholecystectomy by using ultrasound-guided retrolaminar block vs ultrasound-guided thoracic epidural analgesia.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
    <masking_description>Double (participant, outcomes assessor) Anesthetist not sharing in the study will assess patient.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>The duration of post operative analgesia</measure>
    <time_frame>within 24 hours postoperative</time_frame>
    <description>start from retrolaminar or epidural injection of the drug to the first request of analgesia</description>
  </primary_outcome>
  <primary_outcome>
    <measure>The total analgesic dose of morphine</measure>
    <time_frame>within 24 hours postoperative</time_frame>
    <description>total consumption of rescue analgesia (morphine) postoperative</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pain intensity at rest and at cough using Visual Analogue Scale (VAS)</measure>
    <time_frame>30 minutes postoperative</time_frame>
    <description>measured by VAS on 0-10 cm scale (10 means the worst pain and 0 means no pain)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain intensity at rest and at cough using Visual Analogue Scale (VAS)</measure>
    <time_frame>2 hours postoperative</time_frame>
    <description>measured by VAS on 0-10 cm scale (10 means the worst pain and 0 means no pain)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain intensity at rest and at cough using Visual Analogue Scale (VAS)</measure>
    <time_frame>4 hours postoperative</time_frame>
    <description>measured by VAS on 0-10 cm scale (10 means the worst pain and 0 means no pain)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain intensity at rest and at cough using Visual Analogue Scale (VAS)</measure>
    <time_frame>6 hours postoperative</time_frame>
    <description>measured by VAS on 0-10 cm scale (10 means the worst pain and 0 means no pain)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain intensity at rest and at cough using Visual Analogue Scale (VAS)</measure>
    <time_frame>8 hours postoperative</time_frame>
    <description>measured by VAS on 0-10 cm scale (10 means the worst pain and 0 means no pain)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain intensity at rest and at cough using Visual Analogue Scale (VAS)</measure>
    <time_frame>12 hours postoperative</time_frame>
    <description>measured by VAS on 0-10 cm scale (10 means the worst pain and 0 means no pain)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain intensity at rest and at cough using Visual Analogue Scale (VAS)</measure>
    <time_frame>18 hours postoperative</time_frame>
    <description>measured by VAS on 0-10 cm scale (10 means the worst pain and 0 means no pain)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain intensity at rest and at cough using Visual Analogue Scale (VAS)</measure>
    <time_frame>24 hours postoperative</time_frame>
    <description>measured by VAS on 0-10 cm scale (10 means the worst pain and 0 means no pain)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient satisfaction is recorded at the end of 24 hours postoperative</measure>
    <time_frame>24 hours postoperative</time_frame>
    <description>using 5-point Likert-like verbal rating scale by asking the patient about &quot;how he/she evaluated their experience with the analgesic management after the surgery?&quot;5=very satisfied, 4=satisfied, 3= neutral, 2= dissatisfied and 1= very dissatisfied&quot;.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The number of participant with nausea, vomiting, hypotension and bradycardia.</measure>
    <time_frame>24 hours postoperative</time_frame>
    <description>the number of participant with nausea (sensation of being about to vomit), vomiting (the expelling of the food content from the stomach through mouth, it will be treated by 4 mg ondansetron), hypotension (if MAP decreases more than 20% of basal reading it will be treated by 12 mg ephedrine) and bradycardia (if HR less than 50 beats/min it will be treated by 0.5 mg atropine).</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">82</enrollment>
  <condition>Analgesia</condition>
  <arm_group>
    <arm_group_label>group T</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Group (T) (n=41): will receive ultrasound guided thoracic epidural analgesia: 20 ml of bupivacaine 0.25 % plus 5ug/ml adrenaline (1:200000).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>group R</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Group (R) (n=41): will receive bilateral ultrasound guided retrolaminar block analgesia: 20 ml of bupivacaine 0.25 % plus 5ug/ml adrenaline (1:200000).</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Bilateral retrolaminar block</intervention_name>
    <description>in lateral position and after skin sterilization. The spine is palpated from cervical (C7) downward toT8 and point marked to identify the spinous process. The linear high frequency transducer (6-13 MHz) will be placed 1 cm lateral to the midline. The needle (18-22 gauge) is inserted in the plane view of the ultrasound probe to target the T8 and needle is advanced at an angle of 90Ëš to the skin until the needle tip contacted the lamina (6). After negative aspiration, a 20 ml of bupivacaine 0.25 % plus 5ug/ml adrenaline (1:200000) will be injected. The procedure will be repeated following the same steps on the other side.</description>
    <arm_group_label>group R</arm_group_label>
    <other_name>Ultrasound guided retrolaminar block</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Thoracic epidural analgesia</intervention_name>
    <description>In the lateral position, after skin sterilization, Ultrasound with high frequency linear probe (5-13 MHz). Thoracic intervertebral space (T8-9) will be identified by counting from the most prominent thoracic spine (T7). The probe will be used in parasagittal plane 2 cm from midline. The probe will be directed medially to identify the dura matter at the T8-9 intervertebral space</description>
    <arm_group_label>group T</arm_group_label>
    <other_name>Ultrasound guided thoracic epidural</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Written informed consent from the patient.&#xD;
&#xD;
          -  Age: 21-45 years old.&#xD;
&#xD;
          -  Sex: both sex (males and females).&#xD;
&#xD;
          -  Physical status: ASA 1&amp; II.&#xD;
&#xD;
          -  BMI = (25-35 kg/m2).&#xD;
&#xD;
          -  Type of operation: elective laparoscopic cholecystectomy&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Altered mental state.&#xD;
&#xD;
          -  Patients with known history of allergy to study drugs.&#xD;
&#xD;
          -  Advanced hepatic, renal, cardiovascular, and respiratory diseases.&#xD;
&#xD;
          -  Patients with chronic pain.&#xD;
&#xD;
          -  Patients receiving anticoagulants.&#xD;
&#xD;
          -  Contraindications of regional anesthesia, e.g., allergy to local anesthetics,&#xD;
             coagulopathy, or septic focus at site of injection.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dina Salem, MD.</last_name>
    <role>Principal Investigator</role>
    <affiliation>faculty of medicine , Zagazig University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Dina Salem, MD.</last_name>
    <phone>01099333513</phone>
    <phone_ext>002</phone_ext>
    <email>dinamaghraby@yahoo.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Alshimaa Kamel, MD.</last_name>
    <phone>01005593169</phone>
    <phone_ext>002</phone_ext>
    <email>AlshimaaKamel80@yahoo.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>faculty of medicine, Zagazig university</name>
      <address>
        <city>Zagazig</city>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dina Salem, MD</last_name>
      <phone>01099333513</phone>
      <phone_ext>002</phone_ext>
      <email>dinamaghraby@yahoo.com</email>
    </contact>
    <contact_backup>
      <last_name>Alshimaa Kamel, MD</last_name>
      <phone>01005593169</phone>
      <phone_ext>002</phone_ext>
      <email>AlshimaaKamel80@yahoo.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>April 4, 2021</study_first_submitted>
  <study_first_submitted_qc>April 6, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 8, 2021</study_first_posted>
  <last_update_submitted>June 5, 2021</last_update_submitted>
  <last_update_submitted_qc>June 5, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 8, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Zagazig University</investigator_affiliation>
    <investigator_full_name>Dina Abdelhameed Elsadek Salem</investigator_full_name>
    <investigator_title>Principle investigator</investigator_title>
  </responsible_party>
  <keyword>Ultrasound</keyword>
  <keyword>Bilateral retrolaminar</keyword>
  <keyword>Thoracic epidural</keyword>
  <keyword>post operative analgesia</keyword>
  <keyword>Laparoscopic cholecystectomy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Agnosia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

